Home > Income Statement > NEULAND LABORATORIES

NEULAND LABORATORIES
Consolidated Net Profit

    Back to Income Statement
NEULAND LABORATORIES is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for NEULAND LABORATORIES
Please provide your vote to see the results

NEULAND LABORATORIES Last 5 Year Consolidated Net Profit History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Consolidated Net Profit ₹364 Cr₹260 Cr₹300 Cr₹164 Cr₹64 Cr

What is the latest Consolidated Net Profit of NEULAND LABORATORIES ?

The latest Consolidated Net Profit ratio of NEULAND LABORATORIES is ₹364 Cr based on Mar2026 Consolidated results.
Year Consolidated Net Profit
Mar2026₹364 Cr
Mar2025₹260 Cr
Mar2024₹300 Cr
Mar2023₹164 Cr
Mar2022₹64 Cr

How is Consolidated Net Profit of NEULAND LABORATORIES Trending?

Years Consolidated Net Profit % Change
Mar2026 ₹364 Cr
39.94
Mar2025 ₹260 Cr
-13.32
Mar2024 ₹300 Cr
83.51
Mar2023 ₹164 Cr
156.21
Mar2022 ₹64 Cr -

Compare Consolidated Net Profit of peers of NEULAND LABORATORIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NEULAND LABORATORIES ₹27,519.9 Cr 12.8% 14% 43.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹466,431.0 Cr -2.3% 3% 12.3% Stock Analytics
DIVIS LABORATORIES ₹220,115.0 Cr 2.9% 22.7% 25.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹188,853.0 Cr -2.7% 2% 33.9% Stock Analytics
CIPLA ₹119,158.0 Cr 0.1% 3% -7% Stock Analytics
DR REDDYS LABORATORIES ₹98,074.4 Cr 2.4% -12.9% -9.1% Stock Analytics


NEULAND LABORATORIES Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
NEULAND LABORATORIES

12.8%

14%

43.6%

SENSEX

1.3%

1%

-2.9%


You may also like the below Video Courses